je.st
news
Tag: glaxosmithkline
GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas
2016-01-09 20:38:11| Biotech - Topix.net
's stock had its "neutral" rating restated by analysts at BNP Paribas in a report issued on Friday, MarketBeat Ratings reports. They presently have a GBX 1,400 target price on the stock.
Tags: rating
neutral
bnp
reaffirmed
GlaxoSmithKline partners in research to make vaccines cheaper for African babies
2015-12-16 11:46:55| Biotech - Topix.net
GlaxoSmithKline's Philip Leslie and the new vaccine vials which he hopes will make treatments against polio, influenza and gastro cheaper in the developing world. Pharmaceutical giant GlaxoSmithKline has partnered with university researchers in Melbourne to develop a new manufacturing method to make vaccines cheaper for families in Africa and elsewhere in the developing world.
Tags: make
research
partners
african
GlaxoSmithKline plans to seek approval for up to 20 new drugs by 2020, start studies on others
2015-11-04 04:50:02| Biotech - Topix.net
GlaxoSmithKline could seek regulatory approval for up to 20 new medicines before 2020 and some could hit the market by then, enabling it to boost revenue rather than just compensate for declining sales of its older drugs. The British drugmaker said it could start late-stage patient testing in the next two years on about 20 new drugs or new uses for existing ones.
GlaxoSmithKline profits rise 34 percent to $824M
2015-10-29 04:14:48| Biotech - Topix.net
London a British drugmaker GlaxoSmithKline saw third quarter net income rise to $824 million from $614 million a year earlier as it benefits from a recent asset swap with rival Novartis. The company said Wednesday that sales of consumer healthcare products rose 55 percent with the start of over-the-counter sales of Flonase in the U.S. and a strong performance from pain relievers Voltaren and Panadol in Europe.
Tags: percent
rise
profits
glaxosmithkline
GlaxoSmithKline: Unfairly Beaten Given Strategic Direction
2015-10-26 12:51:30| Biotech - Topix.net
GlaxoSmithKline PLC is a global pharmaceutical giant that is trading below intrinsic value. The company's real focus is on scale and innovation - providing much of the world with the drugs and medications it needs while containing an expansive list of patent-protected drugs in late stage development.
Tags: direction
strategic
beaten
glaxosmithkline
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] next »